<SEC-DOCUMENT>0001943462-25-000001.txt : 20250110
<SEC-HEADER>0001943462-25-000001.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110162718
ACCESSION NUMBER:		0001943462-25-000001
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250108
FILED AS OF DATE:		20250110
DATE AS OF CHANGE:		20250110

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Dellora Investments LP
		CENTRAL INDEX KEY:			0001943462
		ORGANIZATION NAME:           	
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34600
		FILM NUMBER:		25523356

	BUSINESS ADDRESS:	
		STREET 1:		283 GREENWICH AVENUE
		STREET 2:		3RD FLOOR
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
		BUSINESS PHONE:		203-632-6341

	MAIL ADDRESS:	
		STREET 1:		283 GREENWICH AVENUE
		STREET 2:		3RD FLOOR
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TENAX THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0000034956
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				262593535
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		101 GLEN LENNOX DRIVE
		STREET 2:		SUITE 300
		CITY:			CHAPEL HILL
		STATE:			NC
		ZIP:			27517
		BUSINESS PHONE:		919-855-2100

	MAIL ADDRESS:	
		STREET 1:		101 GLEN LENNOX DRIVE
		STREET 2:		SUITE 300
		CITY:			CHAPEL HILL
		STATE:			NC
		ZIP:			27517

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OXYGEN BIOTHERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20080703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SYNTHETIC BLOOD INTERNATIONAL INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SINEQUANON CORP
		DATE OF NAME CHANGE:	19901219
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2025-01-08</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000034956</issuerCik>
        <issuerName>TENAX THERAPEUTICS, INC.</issuerName>
        <issuerTradingSymbol>TENX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001943462</rptOwnerCik>
            <rptOwnerName>Dellora Investments LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>283 GREENWICH AVENUE</rptOwnerStreet1>
            <rptOwnerStreet2>3RD FLOOR</rptOwnerStreet2>
            <rptOwnerCity>GREENWICH</rptOwnerCity>
            <rptOwnerState>CT</rptOwnerState>
            <rptOwnerZipCode>06830</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>351071</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The reporting persons are Dellora Investments LP (&quot;Dellora&quot;) and Mr. Kevin Pyun. Dellora is the investment adviser to private funds managed by Dellora that hold securities directly for the benefit of their investors. Dellora may be deemed to beneficially own such securities indirectly as the investment adviser of the private funds and Mr. Pyun may be deemed to beneficially own them indirectly as the control person of Dellora. Each of Dellora and Mr. Pyun disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Dellora Investments LP, /s/ Kevin Pyun, Principal, Dellora Investments GP LLC, its General Partner</signatureName>
        <signatureDate>2025-01-10</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Kevin Pyun, /s/ Kevin Pyun</signatureName>
        <signatureDate>2025-01-10</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
